CMR and LV Noncompaction Does it Matter How We Measure Trabeculations? by Petersen, SE
CMR and LV noncompaction: does it matter how we measure
trabeculations?
Petersen, SE
 
 
 
 
 
10.1016/j.jcmg.2013.03.007
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9652
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
 1
Cardiovascular Magnetic Resonance and Left Ventricular Non-
compaction:  
Does It Matter How We Measure Trabeculations? 
 
Steffen E Petersen, MD DPHIL FESC FACC 
London, United Kingdom 
 
Corresponding author: Steffen E. Petersen, MD DPhil FESC FACC 
Reader in Advanced Cardiovascular Imaging, 
Honorary Consultant Cardiologist, 
Centre Lead for Advanced Cardiovascular Imaging, 
William Harvey Research Institute, 
NIHR Cardiovascular Biomedical Research Unit at Barts, 
The London Chest Hospital, 
Bonner Road, 
London, 
E2 9JX, 
UK 
Email: s.e.petersen@qmul.ac.uk 
 
Acknowledgements: 
This work forms part of the research contributing to the translational research 
portfolio of the Cardiovascular Biomedical Research Unit at Barts which is 
supported and funded by the National Institute for Health Research 
 
 2
Left Ventricular Non-Compaction (LVNC) is an intriguing, but poorly 
understood condition that can lead to heart failure, malignant arrhythmias and 
thromboembolic events. It can be associated with neuromuscular disorders 
and can co-exist with other cardiac malformations (1). 
 
Diagnostic imaging criteria were first described for native echocardiography 
by Chin (2), Jenni (3) and Stollberger (1)  and followed by CMR criteria 
proposed by Petersen (4) and Jacquier (5). It is important to emphasise here 
that currently there is no diagnostic tool, neither genetic nor imaging, that can, 
in all patients, reveal the underlying truth of whether or not somebody is 
affected by LVNC. The absence of such a ‘gold-standard’ is the main reason 
why all cardiac imaging studies have limitations when attempting to determine 
their diagnostic accuracies with a basis of a likely diagnosis of LVNC and not 
a definitive diagnosis. To avoid a circular argument in diagnostic accuracy 
studies for LVNC the imaging findings alone should not be considered 
sufficient for a diagnosis of LVNC, but should be supported with evidence of 
malignant arrhythmias, neuromuscular disorders or a family history of LVNC 
or thromboembolic events. Another observation holds true for most LVNC 
diagnostic accuracy studies: In a derivation dataset, cut-off values for 
continuous variables, such as the non-compaction to compaction ratio, are 
typically determined using receiver-operating characteristics curves and trade 
off sensitivity and specificity according to the purpose of the test; rarely is the 
diagnostic accuracy of a cut-off value validated in a validation dataset. 
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Sensitivity and specificity are independent of the prevalence of disease. A 
useful diagnostic test provides information that changes the likelihood of 
having disease (post-test probability) from the likelihood of having disease 
without the test information (pre-test probability). The positive and negative 
predictive values quantify this information of the test as a function of 
sensitivity, specificity and pre-test probability (this may be the prevalence of 
disease). Figure 1 represents the relationships between pre- and post-test 
probabilities over the entire range of pre-test probabilities given the 
sensitivities and specificities published (4, 5). An uninformative test (50% 
sensitivity and 50% specificity) does not change the probabilities and equals 
the identity line (45 degree line) in the figure. The graph also shows that in the 
range of pre-test probabilities that are consistent with the currently published 
range of LVNC prevalence (0.014 to 0.05%) (6) both CMR criteria do not 
provide sufficient diagnostic information, as the post-test probability remains 
low. Both CMR criteria help refine the post-test probability in the low and 
intermediate pre-test range. Above a pre-test probability of 10%, the post-test 
probability is above 90% for the Petersen criteria showing the value of CMR 
as a rule-in test in such a population. Similarly, the negative CMR test result in 
the same population reduced the post-test probabilities to very low likelihoods 
and thus underlines its potential use as a rule-out test.  
 
Currently no prediction rule is available based on the above clinical 
information to determine the pre-test probability for LVNC. Patients with a 
family history of LVNC, known LVNC complications, associated muscular 
disorders or regional wall motion abnormalities would have higher than 
 4
background prevalence pre-test probabilities of having LVNC. To illustrate the 
use of CMR in diagnosing or excluding LVNC in intermediate probabilities 
consider the following CMR screening in a family with an autosomal dominant 
inheritance pattern. The nephew of an index patient has a pre-test probability 
of 25% compared to the child of the index patient who has 50%. Here, 
positive CMR scans using Petersen criteria lead to a post-test probability of 
having LVNC of 96.6% and 98.9%, respectively. Negative CMR scans lead to 
a post-test probability of having LVNC of 4.5% and 12.4%. (4) 
The clinical value of CMR in the diagnosis of LVNC is currently unclear due to 
a lack of prospective population-based studies including cardiac imaging and 
LVNC cohorts. The natural history of LVNC with normal ejection fraction 
compared to normally functioning and normally trabeculated hearts remains 
unknown and the natural history of LVNC with impaired LV systolic function 
compared to matched dilated cardiomyopathy patients is unclear. This 
information could inform how to best manage such patients. Many open 
questions remain, such as should patients with heavily trabeculated hearts 
and normal function be treated to reduce the likelihood of adverse remodelling 
or thromboembolic events? Should LVNC patients with impaired systolic 
function be managed differently from those with dilated cardiomyopathy? 
 
In this issue of iJACC, Stacy et al. (7) present, for a number of diagnostic 
CMR criteria which are similar but slightly modified compared to those in 
previously published studies, associations with prevalent (existing) heart 
failure and with incident (future) combined clinical events (death, heart failure 
readmission, embolic events or ventricular arrhythmias). The motivation for 
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this retrospective study with chart reviews to determine outcomes is to 
investigate whether end-systolic measures of LVNC are feasible and can 
improve clinical recognition of LVNC. 122 patients (2.5% of the 4,762 patients 
screened) are included as reports mention trabeculations or LVNC. The 
authors find that measures of end-systolic non-compaction to compaction 
ratios (ES-NCCR) are the strongest predictors of not only prevalent heart 
failure (adjusted odds ratio 29.4 (CI: 6.6-125), but also incident combined 
clinical events (adjusted odds ratio 8.6 (CI 2.5-33), albeit with very wide 
confidence interval reflecting uncertainty. This study is welcomed as it 
provides some much-needed insight into the not entirely benign natural 
history of some patients with a LVNC diagnosis based on the CMR findings. 
However, no firm conclusions can be drawn, as to whether ES-NCCR is 
superior to end-diastolic measures for diagnosis of LVNC leading to related 
events. Given the above explanations regarding the relationship of pre-and 
post-test probabilities of LVNC and the arguments presented in Figure 1, it is 
likely that a large proportion of the so-called LVNC population does not have 
the disease. In particular patients with normal ejection fraction may have no 
disease. It is possible that ES-NCCR may identify LVNC patients with more 
pronounced impairment of regional or global dysfunction due to the reduced 
contraction of the trabeculations. Whether this approach is superior to using a 
diastolic measure with attention to regional and global function is unclear. 
Even though the authors adjusted the odds ratios for co-variates including 
heart failure, it is possible that the adjusted odds ratios for end-systolic 
parameters were higher compared to the end-diastolic ones due to the lack of 
contraction of trabeculations when ejection fraction is impaired. Whether end-
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systolic parameters are more useful in diagnosing LVNC or predicting clinical 
events in normal ejection fraction remains unclear. 
The study by Stacey and colleagues is limited by its retrospective nature and 
relatively small sample size, leaving it unable to provide sufficient information 
on the natural history of patients with normal ejection fraction and impaired 
ejection fraction separately (and to compare the latter group to dilated 
cardiomyopathy patients).  
Prospective studies are needed to document the natural progression of LVNC 
and to determine clinical and imaging predictors of adverse outcomes, which 
could be the basis for a simple diagnostic prediction rule. This is a task for a 
coordinated effort between the international imaging and heart muscle 
disease communities to come together to plan, raise funds and organise such 
a study. 
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Figures 
 
Figure 1: Relationship between pre- and post-test probability for published 
sensitivities and specificities to diagnose left ventricular non-compaction. 
Petersen criteria: sensitivity 86%, specificity 99%; Jacquier criteria: sensitivity 
93.7%, specificity 93.7%. An uninformative test has a sensitivity and specificity 
of 50%. In very low pre-test probabilities consistent with the reported LVNC 
prevalence of 0.014 to 0.5% neither CMR criteria are very informative. In low 
and intermediate pre-test probabilities both CMR criteria are informative, one 
slightly better at ruling out disease one better at ruling in disease. 
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